Osteopontin: An Effector and an Effect of Tumor Metastasis
Journal:
Current Molecular Medicine
Volume:
10
Page:
71-81
Author(s):
L. A. Shevde, S. Das, D. W. Clark and R. S. Samant
Trends in Utilization of the Pharmacological Potential of Chalcones
Journal:
Current Clinical Pharmacology
Volume:
5
Page:
1-29
Author(s):
Daniela Ilieva Batovska and Iva Todorova Todorova
Editorial [Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement. PART I. (Executive Editors: Calogero Caruso Thea Magrone and Emilio Jirilllo)]
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
583-583
Author(s):
Calogero Caruso, Thea Magrone and Emilio Jirilllo
Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
584-596
Author(s):
G. Candore, C. Caruso, E. Jirillo, T. Magrone and S. Vasto
Age-Related Inflammation: the Contribution of Different Organs, Tissues and Systems. How to Face it for Therapeutic Approaches
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
609-618
Author(s):
E. Cevenini, C. Caruso, G. Candore, M. Capri, D. Nuzzo, G. Duro, C. Rizzo, G. Colonna-Romano, D. Lio, D. Di Carlo, M. G. Palmas, M. Scurti, E. Pini, C. Franceschi and S. Vasto
A Pilot Study on Prostate Cancer Risk and Pro-Inflammatory Genotypes: Pathophysiology and Therapeutic Implications
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
718-724
Author(s):
C. R. Balistreri, C. Caruso, G. Carruba, V. Miceli, I. Campisi, F. Listi, D. Lio, G. Colonna-Romano and G. Candore
Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
725-733
Author(s):
Cecilia Menna, Fabiola Olivieri, Alfonso Catalano and Antonio Procopio
Polyploidy: The Link Between Senescence and Cancer
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
734-740
Author(s):
G. Mosieniak and E. Sikora
Utility and Limitations of SP600125, an Inhibitor of Stress-Responsive c-Jun N-Terminal Kinase
Journal:
Current Enzyme Inhibition
Volume:
6
Page:
26-33
Author(s):
Shuhei Tanemura, Tokiwa Yamasaki, Toshiaki Katada and Hiroshi Nishina
IP6 in Cancer Therapy: Past, Present and Future
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
1-12
Author(s):
Agata Matejuk and Abulkalam Shamsuddin